No Data
No Data
No Data
No Data
No Data
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company, today announced that it will release financial results for the first quarter of
GlobeNewswireApr 23 04:05
Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)
TipRanksApr 9 19:06
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting With Case Studies Demonstrating Unprecedented Speed and Scale
MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company, today announced it will highlight case studies featuring its Spatial Biol
GlobeNewswireApr 5 20:00
Akoya Biosciences(AKYA.US) Officer Sells US$37,242.75 in Common Stocks
$Akoya Biosciences(AKYA.US)$ Officer McKelligon Brian sold 7,500 shares of Common Stocks on Mar 20, 2024 at an average price of $4.9657 for a total value of $37,242.75.Source: Announcement What is sta
Futu NewsMar 23 06:36
(SEC Amendment) Akoya Biosciences(AKYA.US) Officer Sells US$37,042.5 in Common Stocks
$Akoya Biosciences(AKYA.US)$ Officer McKelligon Brian sold 7,500 shares of Common Stocks on Mar 13, 2024 at an average price of $4.939 for a total value of $37,042.5.Source: Announcement What is state
Futu NewsMar 23 06:31
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider
Bringing End-to-End Spatial Biology Solutions to Life Sciences Researchers for Advanced Spatial Proteomics AnalysisWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecula
BusinesswireMar 19 19:00
No Data
No Data